⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL3004626 | 1.00 | — | — | |
| SCHEMBL340276 | 0.95 | — | — | |
| SCHEMBL29062408 | 0.90 | — | — | |
| SCHEMBL31520155 | 0.90 | — | — | |
| SCHEMBL14957045 | 0.90 | — | — | |
| SCHEMBL29062406 | 0.90 | — | — | |
| SCHEMBL31520152 | 0.90 | — | — | |
| SCHEMBL3003241 | 0.90 | — | — | |
| SCHEMBL14957648 | 0.90 | — | — | |
| SCHEMBL562636 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115403620-A | Organic phosphonite and preparation method and application thereof | 威海海润新材料科技有限公司 | 2022-11-29 | — | — | CN | disclosed |
| US-20130126805-A1 | Method For Producing Alkylphosphonous Acid Salts | CLARIANT FINANCE (BVI) LIMITED (VG) | 2013-05-23 | — | — | US | disclosed |
| US-8293938-B2 | Alkylphosphonous acids, salts and esters, methods for the production thereof, and use of the same | CLARIANT FINANCE (BVI) LIMITED (VG) | 2012-10-23 | — | — | US | disclosed |
| US-20100190901-A1 | Alkylphosphonous Acids, Salts and Esters, Methods for the Production Thereof, and Use of the Same | CLARIANT FINANCE (BVI) LIMITED (VG) | 2010-07-29 | — | — | US | disclosed |
| EP-0038778-A2 | Alkyl phosphonites, process for their preparation and the use of alkyl phosphonites as fungicides | CIBA-GEIGY AG (CH) | 1981-10-28 | — | — | EP | disclosed |